1. Taiwan Stocks

  2. •

    Commercial services

  3. •

    Miscellaneous commercial services
BioGend Therapeutics Co., Ltd.

BioGend Therapeutics Co., Ltd.

TTPEX:6733
23.55
TWD
-0.40
(-1.67%)
3.25BMarket Cap
Nov 05Next Earn

Latest Stock Split

Dec 21, 2022

230:227

For every 227 shares held, investors received 230. The price per share adjusted from $22.15 to $21.86.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data
Stock Splits APIChatGPT

Stock Split History

  1. Dec 21, 2022
    Before$22.15
    Split ratio230:227
    After$21.86
    Forward

About BioGend Therapeutics Co., Ltd. stock splits

BioGend Therapeutics Co., Ltd. (TPEX:6733) operates in the Miscellaneous commercial services industry.

BioGend Therapeutics Co., Ltd. company overview

When did BioGend Therapeutics Co., Ltd. stock split?

BioGend Therapeutics Co., Ltd.'s most recent stock split was on December 21, 2022. It was a 230-for-227 forward split, so shareholders received 230 shares for every 227 they held.

How many times has BioGend Therapeutics Co., Ltd. stock split?

BioGend Therapeutics Co., Ltd. has split its stock once. This history records one forward split, on December 21, 2022.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In BioGend Therapeutics Co., Ltd.'s 230-for-227 split on December 21, 2022, every 227 shares became 230 shares.

Will BioGend Therapeutics Co., Ltd. split its stock again?

BioGend Therapeutics Co., Ltd. has not announced a new split in our records. Its most recent split was on December 21, 2022, 3 years ago. Companies announce splits in advance, and any new TPEX:6733 split will appear on this page.